Allied Market Research
Loading...
0
New
New
2021
Digital Therapeutics Market

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardio Vascular Diseases (CVD), Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders, and Others), Product Type (Software, and Devices), and Sales Channel (Business-to-Business and Business-to-Consumers): Global Opportunity Analysis and Industry Forecast, 2021–2030

A01787
Pages: 322
Nov 2021 | 30529 Views
   
Author(s) : Sanjivan Gill, Vikita Thakur , Onkar Sumant
Tables: 131
Charts: 65
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Digital Therapeutics Market

Request Now !

Digital Therapeutics (DTx) Market Statistics- 2030

The global digital therapeutics market was valued at $3,537.29 million in 2020, and is projected to reach $23,569.38 million by 2030, registering a CAGR of 20.6% from 2021 to 2030. Digital therapeutics provides evidence-based therapeutic interventions to patients. It is delivered through software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. The design, clinical validation, usability, and data security of digital therapeutics products are all based on advanced technology best practices. 

The digital therapeutics market is expected to be positively impacted by the COVID-19 pandemic, owing to rise in adoption of digital health due to COVID-19 restrictions and a global shift towards digital health.

In addition, these products are reviewed and approved by regulatory bodies before use. Digital therapeutics market includes a wide range of product types such as mobile applications, wearable devices, and sensors. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics is a subdivision of digital health, not all digital health solutions are digital therapeutics. The difference between digital health and digital therapeutics is based on the clinical outcomes for patients.

Digital-Therapeutics-Market-2021-2030

Get more information on this report : Request Sample Pages

Increase in adoption of smartphones and tablets, coupled with healthcare apps, growth in need to control healthcare cost, significant benefits to the entire healthcare continuum and rise in incidences of chronic diseases drive growth of the global digital therapeutics market. For instance, according to the World Health Organization (WHO) in 2020, it is estimated that 463 million adults have diabetes worldwide million people are living with diabetes all over the world. By 2045, projections show this number is expected to rise to around 629 million diabetics globally. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the digital therapeutics market growth. The impact of the driving factors is expected to surpass that of the restraints. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future. 

Furthermore, a strong pipeline of potential products that are expected to be launched during the forecast period also provide lucrative opportunities in the future. For instance, potential products of pear therapeutics, clinical therapeutics products in phase III are Pear-011 (anxiety GAD), Pear-015 (depression MDD) which are used in the treatment of adults with chronic insomnia and depression and CT-152 (major depressive disorder), CT-155 (schizophrenia) are used in the treatment of adults suffering from schizophrenia and depression. Thus, presence of several products in pipeline in late stage of development is expected to provide lucrative opportunities for the growth of the digital therapeutics market.

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Due to the COVID-19 pandemic, governments across the globe announced country-wide lockdowns as well as social distancing measures to prevent collapse of the healthcare system. Governments have also issued limitations and bans on medical procedures and elective surgeries. These restrictions continue to impact the growth of various industries, and the immediate impact of the outbreak varies from industry to industry.

The distribution, production, and supply chain have been affected, due to the implementation of lockdown across the globe

The overall impact of COVID-19 remains positive for digital therapeutics market. Owing to awareness regarding importance of digital health, rise in prevalence of mental illness, and increase in rate of drug abuse globally. Moreover, during this pandemic, people had to stay at home, which led to less physical activity, unhealthy lifestyle, and mental stress and, in turn, increasing the prevalence of chronic diseases. Hence, there is a rise in demand for Digital therapeutics (DTx) devices and software across the globe. 

Recent easing of regulatory approvals for Digital therapeutics (DTx) based treatments further drives the growth of the market. For instance, the U.S. FDA issued temporary guidance for Pear Therapeutics products for mental health amidst the COVID-19 pandemic. Furthermore, it suggests that regulatory agencies acknowledge the importance of digital therapeutics products. 

In addition, the U.S. digital health companies raised $5.4 billion in venture funding across the first six months of 2020, which is a record high in the history of digital health funding signifying that investor also sees necessity of these solutions. Hence, the COVID-19 pandemic is expected to have a positive impact on the digital therapeutics (DTx) market.

Digital Therapeutics Market Segmentation  

The digital therapeutics market is segmented on the basis of application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product type, it is classified into software and devices. By sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). The business-to-business (B2B) segment is categorized into employers, healthcare providers, and others. The business-to-consumers segment is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Application segment review

By application, the diabetes segment was the major revenue contributor, and is projected to grow significantly during the forecast period. owing to the high prevalence of obesity in developing countries, as well as significant risks and economic costs associated with obesity related diseases, which further drives the growth of the global digital therapeutics market.

Digital Therapeutics Market
By Application

Your browser does not support the canvas element.

Diabetes segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Product segment review

By product, the software segment was the major revenue contributor, and is projected to grow significantly, owing to the increased penetration of smart phones and other smart devices mostly in the developing economies. For instance, according to a survey report by Pew Research Center, the U.S. had a smartphone adoption rate of 72.7% % in 2021. These further increases use of this healthcare application.

Digital Therapeutics Market
By Product

Your browser does not support the canvas element.

Software segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Sales Channel segment review

By sales channel, the business to costumer segment was the major revenue contributor, and is projected to grow significantly during the forecast period, owing to increase in prevalence of chronic diseases such as heart diseases, high blood pressure, diabetes, and obesity, which can be treated by patients only by tracking their physiological data and taking suggestions from online healthcare professionals are the key factors anticipated to the growth of digital therapeutics market. 

Digital Therapeutics Market
By Sales Channel

Your browser does not support the canvas element.

Business to Consumers segements holds a dominant position in 2020 and continue to maintain lead in the forecast year

Get more information on this report : Request Sample Pages

Major key players operating in the digital therapeutics market include 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Happify, Inc., Kaia Health, Livongo Health, Inc., Medtronic Plc., Omada Health, Inc., Pear Therapeutics, Inc., Proteus Digital Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Welldoc, Inc. Other players operating in the digital therapeutics market include GlaxoSmithKline, Mango Health Inc., Veeva Systems, Healthmine Inc., Blue Mesa, Virta Health Corp, and Glooko Inc.

Digital Therapeutics Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America region holds the dominant position in 2020 and would exhibit the highest CAGR of 19.5 % during 2021-2030

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the digital therapeutics market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers digital therapeutics analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global digital therapeutics market growth.

Key Market Segments

By application

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Disease
  • Smoking Cessation
  • Gastrointestinal Disorder (GID)
  • Others

By Product Type

  • Software
  • Device

By Sales Channel

  • Business-to-Business (B2B)
    • Employer
    • Healthcare Provider
    • Others
  • Business-to-Consumer (B2C)
    • Patient
    • Caregiver

Key Market Players 

  • 2MORROW, Inc.
  • Akili Interactive Labs, Inc.
  • Click Therapeutics, Inc.
  • Fitbit, Inc. (Twine Health, Inc.)
  • Happify, Inc.
  • Kaia Health 
  • Livongo Health, Inc.
  • Medtronic Plc.
  • Omada Health, Inc.
  • Pear Therapeutics, Inc.
  • Proteus Digital Health, Inc.
  • Resmed, Inc. (Propeller Health)
  • Voluntis, Inc.
  • Welldoc, Inc.
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key Market Segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top player positioning, 2020
3.4.Porter’s five forces analysis
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in adoption of smartphones and tablets, coupled with healthcare apps
3.5.1.2.Rise in need to control healthcare costs
3.5.1.3.Rise in incidences of chronic diseases
3.5.1.4.Significant benefits to the entire healthcare continuum

3.5.2.Restraints

3.5.2.1.Lack of awareness regarding digital therapeutics in developing countries
3.5.2.2.Patient data privacy concerns

3.5.3.Opportunity

3.5.3.1.Extensive product pipeline

3.6.Impact analysis of COVID-19 on the digital therapeutics market
3.7.Impact of government regulations on global digital therapeutics market

3.7.1.U.S. FDA’s premarket clearance and approval requirements
3.7.2.European Union premarket clearance and approval requirements
3.7.3.Japan premarket clearance and approval requirements

3.8.Strategy adopted by top 10 start-ups

3.8.1.Meru Health, Inc.
3.8.2.Bold Health Limited
3.8.3.BehaVR, LLC
3.8.4.Naluri Hidup Sdn Bhd
3.8.5.Big Health
3.8.6.Hinge Health, Inc.
3.8.7.Glooko, Inc.
3.8.8.Holmusk Pte. Ltd.
3.8.9.Wellthy Therapeutics Pvt Ltd.
3.8.10.Virta Health Corp.

3.9.Key digital technologies for digital therapeutics

3.9.1.Mobile health (mHealth)
3.9.2.Personalized healthcare
3.9.3.Digital Cognitive Behavior Therapy (CBT)
3.9.4.Wearable devices and sensors

3.10.Necessary human resources required for digital therapeutics development
3.11.Usage of patient data acquired from digital therapeutics

3.11.1.Types of personal information that are collected by DTx companies

CHAPTER 4:DIGITAL THERAPEUTICS MARKET, BY APPLICATION

4.1.Overview

4.1.1.Market size and forecast

4.2.Diabetes

4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Obesity

4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Cardiovascular diseases

4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Central nervous system (CNS) diseases

4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

4.6.Gastrointestinal disorder

4.6.1.Key market trends and growth opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country

4.7.Respiratory diseases

4.7.1.Key market trends and growth opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country

4.8.Smoking cessation

4.8.1.Key market trends and growth opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country

4.9.Others

4.9.1.Key market trends and growth opportunities
4.9.2.Market size and forecast
4.9.3.Market analysis, by country

CHAPTER 5:DIGITAL THERAPEUTICS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Software

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Devices

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

CHAPTER 6:DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Business-to-business (B2B)

6.2.1.Market size and forecast, by type

6.2.1.1.Employer

6.2.1.1.1.Market size and forecast

6.2.1.2.Healthcare Providers

6.2.1.2.1.Market size and forecast

6.2.1.3.Others

6.2.1.3.1.Market size and forecast

6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Business-to-consumers

6.3.1.Market size and forecast, by type

6.3.1.1.Patients

6.3.1.1.1.Market size and forecast

6.3.1.2.Caregivers

6.3.1.2.1.Market size and forecast

6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

CHAPTER 7:DIGITAL THERAPEUTICS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America digital therapeutics market, by country
7.2.3.North America digital therapeutics market, by application
7.2.4.North America digital therapeutics market, by product type
7.2.5.North America digital therapeutics market, by sales channel

7.2.5.1.U.S.

7.2.5.1.1.U.S. digital therapeutics market, by application
7.2.5.1.2.U.S digital therapeutics market, by product type
7.2.5.1.3.U.S. digital therapeutics market, by sales channel

7.2.5.2.Canada

7.2.5.2.1.Canada digital therapeutics market, by application
7.2.5.2.2.Canada digital therapeutics market, by product type
7.2.5.2.3.Canada digital therapeutics market, by sales channel

7.2.5.3.Mexico.

7.2.5.3.1.Mexico digital therapeutics market, by application
7.2.5.3.2.Mexico digital therapeutics market, by product type
7.2.5.3.3.Mexico digital therapeutics market, by sales channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe digital therapeutics market, by country
7.3.3.Europe digital therapeutics market, by application
7.3.4.Europe digital therapeutics market, by product type
7.3.5.Europe digital therapeutics market, by sales channel

7.3.5.1.U.K

7.3.5.1.1.UK digital therapeutics market, by application
7.3.5.1.2.UK digital therapeutics market, by product type
7.3.5.1.3.UK digital therapeutics market, by sales channel

7.3.5.2.Germany.

7.3.5.2.1.Germany digital therapeutics market, by application
7.3.5.2.2.Germany digital therapeutics market, by product type
7.3.5.2.3.Germany digital therapeutics market, by sales channel

7.3.5.3.France.

7.3.5.3.1.France digital therapeutics market, by application
7.3.5.3.2.France digital therapeutics market, by product type
7.3.5.3.3.France digital therapeutics market, by sales channel

7.3.5.4.Italy

7.3.5.4.1.Italy digital therapeutics market, by application
7.3.5.4.2.Italy digital therapeutics market, by product type
7.3.5.4.3.Italy digital therapeutics market, by sales channel

7.3.5.5.Spain

7.3.5.5.1.Spain digital therapeutics market, by application
7.3.5.5.2.Spain digital therapeutics market, by product type
7.3.5.5.3.Spain digital therapeutics market, by sales channel

7.3.5.6.Rest of Europe

7.3.5.6.1.Rest of Europe digital therapeutics market, by application
7.3.5.6.2.Rest of Europe digital therapeutics market, by product type
7.3.5.6.3.Rest of Europe digital therapeutics market, by sales channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific digital therapeutics market, by country
7.4.3.Asia-Pacific digital therapeutics market, by application
7.4.4.Asia-Pacific digital therapeutics market, by product type
7.4.5.Asia-Pacific digital therapeutics market, by sales channel

7.4.5.1.Japan

7.4.5.1.1.Japan digital therapeutics market, by application
7.4.5.1.2.Japan digital therapeutics market, by product type
7.4.5.1.3.Japan digital therapeutics market, by sales channel

7.4.5.2.China

7.4.5.2.1.China digital therapeutics market, by application
7.4.5.2.2.China digital therapeutics market, by product type
7.4.5.2.3.China digital therapeutics market, by sales channel

7.4.5.3.Australia

7.4.5.3.1.Australia digital therapeutics market, by application
7.4.5.3.2.Australia digital therapeutics market, by product type
7.4.5.3.3.Australia digital therapeutics market, by sales channel

7.4.5.4.India

7.4.5.4.1.India digital therapeutics market, by application
7.4.5.4.2.India digital therapeutics market, by product type
7.4.5.4.3.India digital therapeutics market, by sales channel

7.4.5.5.South Korea

7.4.5.5.1.South Korea digital therapeutics market, by application
7.4.5.5.2.South Korea digital therapeutics market, by product type
7.4.5.5.3.South Korea digital therapeutics market, by sales channel

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Rest of Asia-Pacific digital therapeutics market, by application
7.4.5.6.2.Rest of Asia-Pacific digital therapeutics market, by product type
7.4.5.6.3.Rest of Asia-Pacific digital therapeutics market, by sales channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA digital therapeutics market, by country
7.5.3.LAMEA digital therapeutics market, by application
7.5.4.LAMEA digital therapeutics market, by product type
7.5.5.LAMEA digital therapeutics market, by sales channel

7.5.5.1.Brazil

7.5.5.1.1.Brazil digital therapeutics market, by application
7.5.5.1.2.Brazil digital therapeutics market, by product type
7.5.5.1.3.Brazil digital therapeutics market, by sales channel

7.5.5.2.Turkey

7.5.5.2.1.Turkey digital therapeutics market, by application
7.5.5.2.2.Turkey digital therapeutics market, by product type
7.5.5.2.3.Turkey digital therapeutics market, by sales channel

7.5.5.3.Saudi Arabia

7.5.5.3.1.Saudi Arabia digital therapeutics market, by application
7.5.5.3.2.Saudi Arabia digital therapeutics market, by product type
7.5.5.3.3.Saudi Arabia digital therapeutics market, by sales channel

7.5.5.4.South Africa

7.5.5.4.1.South Africa digital therapeutics market, by application
7.5.5.4.2.South Africa digital therapeutics market, by product type
7.5.5.4.3.South Africa digital therapeutics market, by sales channel

7.5.5.5.Rest of LAMEA

7.5.5.5.1.Rest of LAMEA digital therapeutics market, by application
7.5.5.5.2.Rest of LAMEA digital therapeutics market, by product type
7.5.5.5.3.Rest of LAMEA digital therapeutics market, by sales channel

CHAPTER 8:COMPANY PROFILES

8.1.2MORROW, INC.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments

8.2.AKILI INTERACTIVE LABS, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio
8.2.4.Key strategic moves and developments

8.3.CLICK THERAPEUTICS, INC.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments

8.4.FITBIT, INC. (TWINE HEALTH, INC.)

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Product portfolio
8.4.4.Business performance
8.4.5.Key strategic moves and developments

8.5.HAPPIFY, INC.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Product portfolio
8.5.4.Key strategic moves and developments

8.6.KAIA HEALTH

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Product portfolio
8.6.4.Key strategic moves and developments

8.7.MEDTRONIC PLC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.OMADA HEALTH, INC.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments

8.9.PEAR THERAPEUTICS, INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.9.4.Key strategic moves and developments

8.10.PROTEUS DIGITAL HEALTH, INC.

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Key strategic moves and developments

8.11.RESMED, INC. (PROPELLER HEALTH)

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Business performance
8.11.6.Key strategic moves and developments

8.12.TELADOC HEALTH, INC.(LIVONGO HEALTH)

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Product portfolio
8.12.4.Business performance
8.12.5.Key strategic moves and developments

8.13.VOLUNTIS, INC.

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance
8.13.6.Key strategic moves and developments

8.14.WELLDOC, INC.

8.14.1.Company overview
8.14.2.Company snapshot
8.14.3.Operating business segments
8.14.4.Product portfolio
8.14.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.DIGITAL THERAPEUTIC PRODUCT LIST
TABLE 02.FDA CLASSIFICATION OF MEDICAL DEVICES
TABLE 03.DIGITAL SKILLS REQUIRED FOR EMPLOYEES DEDICATED FOR DTX DEVELOPMENTS
TABLE 04.RANGE OF NUMBER OF EMPLOYEES WITH DIGITAL SKILLS DEDICATED FOR DIGITAL THERAPEUTICS DEVELOPMENTS,  BY COMPANY
TABLE 05.GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 06.DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2020-2030 ($MILLION)
TABLE 07.DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2020-2030 ($MILLION)
TABLE 08.DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2020–2030 ($MILLION)
TABLE 09.DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 2020-2030 ($MILLION)
TABLE 10.SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 11.DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 2020-2030 ($MILLION)
TABLE 12.DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2020-2030 ($MILLION)
TABLE 13.DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2020-2030 ($MILLION)
TABLE 14.DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 15.GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 16.DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS
TABLE 17.GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 2020-2030 ($MILLION)
TABLE 18.GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 19.GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020-2030 ($MILLION)
TABLE 20.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 2020-2030 ($MILLION)
TABLE 21.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 2020-2030 ($MILLION)
TABLE 22.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 2020-2030 ($MILLION)
TABLE 23.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 2020-2030 ($MILLION)
TABLE 24.DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 25.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 28.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 29.U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 30.U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 31.U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020-2030 ($MILLION)
TABLE 32.CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 33.CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 34.CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 35.MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 36.MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 37.MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 38.EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 39.EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 40.EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 41.EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 42.UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 43.UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 44.UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 45.GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 46.GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 47.GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 48.FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 49.FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 50.FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 51.ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 52.ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 53.ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 54.SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 55.SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 56.SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 57.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 58.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 59.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 60.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 61.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 62.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 63.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 64.JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 65.JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 66.JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 67.CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 68.CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 69.CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 70.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 71.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 72.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 73.INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 74.INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 75.INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 76.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 77.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 78.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 80.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 81.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 82.LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 83.LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 84.LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 85.LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 86.BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 87.BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 88.BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 89.TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 90.TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 91.TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 92.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 93.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 94.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 95.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 96.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 97.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 98.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 99.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 100.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2020–2030 ($MILLION)
TABLE 101.2MORROW: COMPANY SNAPSHOT
TABLE 102.2MORROW: PRODUCT PORTFOLIO
TABLE 103.AKILI: COMPANY SNAPSHOT
TABLE 104.AKILI: PRODUCT PORTFOLIO
TABLE 105.CLICK THERAPEUTICS: COMPANY SNAPSHOT
TABLE 106.CLICK THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 107.FITBIT: COMPANY SNAPSHOT
TABLE 108.FITBIT: PRODUCT PORTFOLIO
TABLE 109.HAPPIFY: COMPANY SNAPSHOT
TABLE 110.HAPPIFY: PRODUCT PORTFOLIO
TABLE 111.KAIA: COMPANY SNAPSHOT
TABLE 112.KAIA: PRODUCT PORTFOLIO
TABLE 113.MEDTRONIC: COMPANY SNAPSHOT
TABLE 114.MEDTRONIC: OPERATING SEGMENTS
TABLE 115.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 116.OMADA: COMPANY SNAPSHOT
TABLE 117.OMADA: PRODUCT PORTFOLIO
TABLE 118.PEAR: COMPANY SNAPSHOT
TABLE 119.PEAR: PRODUCT PORTFOLIO
TABLE 120.PROTEUS: COMPANY SNAPSHOT
TABLE 121.PROTEUS: PRODUCT PORTFOLIO
TABLE 122.RESMED: COMPANY SNAPSHOT
TABLE 123.RESMED: OPERATING SEGMENTS
TABLE 124.RESMED: PRODUCT PORTFOLIO
TABLE 125.TELADOC: COMPANY SNAPSHOT
TABLE 126.TELADOC: PRODUCT PORTFOLIO
TABLE 127.VOLUNTIS: COMPANY SNAPSHOT
TABLE 128.VOLUNTIS: OPERATING SEGMENTS
TABLE 129.VOLUNTIS: PRODUCT PORTFOLIO
TABLE 130.WELLDOC: COMPANY SNAPSHOT
TABLE 131.WELLDOC: PRODUCT PORTFOLIO

LIST OF FIGURES 

FIGURE 01.DIGITAL THERAPEUTICS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKET IN DIGITAL THERAPEUTICS MARKET, 2020
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 06.TOP PLAYER POSITIONING, 2020
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH BARGAINING POWER OF BUYERS
FIGURE 09.LOW THREAT OF SUBSTITUTION
FIGURE 10.MODERATE THREAT OF NEW ENTRANT
FIGURE 11.MODERATE COMPETITIVE RIVALRY
FIGURE 12.GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13.DIGITAL THERAPEUTICS MARKET, BY APPLICATION
FIGURE 14.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY COUNTRY, 2020 & 2030, ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY,  2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020& 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES,  BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER,  BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY,  2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY,  2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.DIGITAL THERAPEUTICS MARKET, BY PRODUCT
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY,  2020 & 2030 (%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY,  2020 & 2030 (%)
FIGURE 25.DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL
FIGURE 26.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER,  2020-2030 ($MILLION)
FIGURE 27.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 2020-2030 ($MILLION)
FIGURE 28.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS,  2020-2030 ($MILLION)
FIGURE 29.COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2020 & 2030 ($MILLION)
FIGURE 30.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS,  2020-2030 ($MILLION)
FIGURE 31.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS,  2020-2030 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2020 & 2030 ($MILLION)
FIGURE 33.U.S. DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 34.CANADA. DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 35.MEXICO DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 36.U.K DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 37.GERMANY DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 38.FRANCE DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 39.ITALY DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 40.SPAIN DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 41.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 42.JAPAN DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 43.CHINA DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 44.AUSTRALIA DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 45.INDIA DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 46.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 47.REST OF ASIA PACIFIC DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 48.BRAZIL DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 49.TURKEY DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 50.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 51.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 52.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, 2020-2030 ($MILLION)
FIGURE 53.FITBIT: NET SALES, 2017–2019 ($MILLION)
FIGURE 54.FITBIT: NET SALES, BY REGION, 2019 (%)
FIGURE 55.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 56.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 57.MEDTRONIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 58.RESMED: NET SALES, 2018–2020 ($MILLION)
FIGURE 59.RESMED: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 60.RESMED: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 61.TELADOC: NET SALES, 2018–2020 ($MILLION)
FIGURE 62.TELADOC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 63.VOLUNTIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 64.VOLUNTIS: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 65.VOLUNTIS: REVENUE SHARE, BY REGION, 2020 (%)


 
 

Digital therapeutics deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. 

The digital therapeutics market has piqued the interest of healthcare providers, patients, and practitioners, owing to several benefits offered by these devices to reduce healthcare expenditure, improve patient & doctor communication, and manage patient health efficiently. There have been remarkable technological advancements in development of novel digital therapeutics applications to provide advanced management options for chronic disease patients and to maintain healthy lifestyles. As the market is saturated and is growing at a steady rate in developed nations, Asia-Pacific and LAMEA are expected to offer high growth opportunities to key players in this market.

Furthermore, significant advancements in the applications of digital therapeutic products with increase in clinically backed researches and advanced hardware and software are projected to increase the usage rate of digital therapeutics globally. Presently, rapid adoption of digital therapeutics is witnessed in the world for use of novel apps for wellness management such as fitness, diet & nutrition, diabetes, obesity, sleep apnea, respiratory disorder, and lifestyle & stress.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of digital therapeutics Market is $23,569.38 Million in 2030

A. The market value of digital therapeutics in 2020 was 3,537.29 million in 2020

A. The top companies that hold the market share in digital therapeutics Market are include 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc.

A. The forecast period in the report is from 2021 to 2030

A. The market value of digital therapeutics in 2020 was 3,537.29 million in 2020

A. The base year for the report is 2020

A. Yes, digital therapeutics Market companies are profiled in the report

A. The top companies that hold the market share in digital therapeutics Market are include 2MORROW, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., Fitbit, Inc.

A. No, there is no value chain analysis provided in the digital therapeutics Market report

A. The key trends in the digital therapeutics Market areincrease in prevalence of chronic disease along with rise in elderly population are the key factors driving the market growth.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Digital Therapeutics Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2021–2030

Published in Feb 2022

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers